Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 16, 2025
Protracted SARS-CoV-2 Infection in B-cell Depleted Patients: Immunologic andiral Characteristics and Response to Dual and Extended Antiviral Therapy
Jessica S Little, Gregory E Edelstein, Zoe Swank, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 27, 2024
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults
Christina A Rostad, Robert L Atmar, Emmanuel B Walter, et al.
Science (New York, N.Y.)
|
December 2, 2021
Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain
Katherine G Nabel, Sarah A Clark, Sundaresh Shankar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 10, 2024
COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled Trials
Amy C Sherman, Jessica Tuan, Valeria D Cantos, et al.
Open Forum Infectious Diseases
|
March 4, 2024
Neuroinvasive <i>Bacillus cereus</i> Infection in Immunocompromised Hosts: Epidemiologic Investigation of 5 Patients With Acute Myeloid Leukemia
Jessica S Little, Cassie Coughlin, Candace Hsieh, et al.
Biorxiv : the Preprint Server for Biology
|
May 25, 2021
Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunity
Etsuro Nanishi, Francesco Borriello, Timothy R O'Meara, et al.
Science Translational Medicine
|
November 16, 2021
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice
Etsuro Nanishi, Francesco Borriello, Timothy R O'Meara, et al.
Nature Medicine
|
August 28, 2023
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
Angela R Branche, Nadine G Rouphael, David J Diemert, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 28, 2022
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses
Angela R Branche, Nadine G Rouphael, David J Diemert, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 16, 2025
Protracted SARS-CoV-2 Infection in B-cell Depleted Patients: Immunologic andiral Characteristics and Response to Dual and Extended Antiviral Therapy
Jessica S Little, Gregory E Edelstein, Zoe Swank, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 27, 2024
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults
Christina A Rostad, Robert L Atmar, Emmanuel B Walter, et al.
Science (New York, N.Y.)
|
December 2, 2021
Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain
Katherine G Nabel, Sarah A Clark, Sundaresh Shankar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 10, 2024
COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled Trials
Amy C Sherman, Jessica Tuan, Valeria D Cantos, et al.
Open Forum Infectious Diseases
|
March 4, 2024
Neuroinvasive <i>Bacillus cereus</i> Infection in Immunocompromised Hosts: Epidemiologic Investigation of 5 Patients With Acute Myeloid Leukemia
Jessica S Little, Cassie Coughlin, Candace Hsieh, et al.
Biorxiv : the Preprint Server for Biology
|
May 25, 2021
Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunity
Etsuro Nanishi, Francesco Borriello, Timothy R O'Meara, et al.
Science Translational Medicine
|
November 16, 2021
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice
Etsuro Nanishi, Francesco Borriello, Timothy R O'Meara, et al.
Nature Medicine
|
August 28, 2023
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
Angela R Branche, Nadine G Rouphael, David J Diemert, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 28, 2022
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses
Angela R Branche, Nadine G Rouphael, David J Diemert, et al.
Page
of 6